Stockscreener 앱 받기
416.30
1.54%
6.32
시간 외 거래:
416.30
Elevance Health Inc 주식(ELV)의 최신 뉴스
Humana, Elevance, Aetna Face DOJ Lawsuit Over Illegal Kickback Scheme, Discrimination Against Disabled People - Benzinga
Investors Met With Slowing Returns on Capital At Elevance Health (NYSE:ELV) - Yahoo Finance
US accuses health insurers, brokers of Medicare Advantage kickback scheme - Reuters
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Today - Benzinga
US Claims Medicare Insurers, Brokers Used Illegal Kickbacks - Yahoo Finance
DOJ accuses health insurance giants of role in Medicare kickback scheme - Cleveland.com
Justice Department hits Aetna, Humana, Elevance Health with Medicare Advantage kickback complaint - Fierce Healthcare
Elevance Health Insiders Sell US$6.9m Of Stock, Possibly Signalling Caution - Yahoo Finance
Inova and Anthem Announce New Contract for Virginians - Business Wire
Elevance Health, Inc. (ELV): Among the Best Stocks to Buy According to D1 Capital’s Daniel Sundheim - Insider Monkey
Elevance Curbs Online Medicare Sign-Ups as Expenses Rise (ELV) - Bloomberg
Mental health network misled policyholders about provider options, lawsuit claims - Reuters
Elevance Nurses Say Their Right To OT Is Beyond Dispute - Law360
Let’s talk tariffs, and no Amazon Prime subscription with your MA plan - statnews.com
Elevance Health to slash Medicare Advantage marketing - Modern Healthcare
Is Elevance (ELV) an Attractively Valued Stock? - MSN
Elevance Health’s MLR Beat Encourages Worried Wall Street - AIS Health
Argus Adjusts Price Target on Elevance Health to $465 From $450 - marketscreener.com
‘Medicaid to the Rescue,’ Says Wall St. Analyst About Elevance Health (ELV) Stock - markets.businessinsider.com
Elevance Health (ELV) Gets a Buy from Barclays - The Globe and Mail
Elevance Health: Carelon Growth, Not Fully Appreciated (NYSE:ELV) - Seeking Alpha
Elevance health projects $34.15-$34.85 EPS for 2025 with focus on Carelon expansion - MSN
Deutsche Bank Cuts Elevance Health Price Target to $463 From $465, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts Price Target on Elevance Health to $488 From $461, Maintains Buy Rating - marketscreener.com
Cantor maintains Elevance stock with $485 target, Overweight rating - Investing.com
Why Elevance Health, Inc. (ELV) is Among the Best Stocks That Will Always Grow - Yahoo Finance
Elevance Health (ELV) Maintains Dividend, Affirms 2025 Outlook - GuruFocus
Elevance Health Inc. (NYSE:ELV) Q1 2025 Earnings Call Transcript - Insider Monkey
Barclays Increases Price Target for Elevance Health (ELV) to $52 - GuruFocus
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... - Yahoo Finance
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... By GuruFocus - Investing.com Canada
Elevance Health Inc (ELV) Q1 2025 Earnings Call Highlights: Strong EPS Growth and Strategic Expansions - GuruFocus
Elevance Health: Q1 Earnings Snapshot - CT Insider
Elevance Health Reports Strong Q1 2025 Results - TipRanks
Elevance dodges high MA medical costs that sunk United - Healthcare Brew
Elevance Health Q1 2025 Earnings Call Highlights - TipRanks
Despite Medicaid pressures, Elevance reports strong Q1 earnings - InsuranceNewsNet
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums - Yahoo Finance
Elevance Health, Inc. SEC 10-Q Report - TradingView
Elevance Health execs seek to ease Wall Street's concerns about elevated MA costs - Fierce Healthcare
Elevance Health (ELV) Q1 2025 Earnings Report Highlights Growth - GuruFocus
Elevance Health Inc (ELV) Shares Down 4.72% on Apr 21 - GuruFocus
Barclays Adjusts Elevance Health Price Target to $522 From $512, Keeps Overweight Rating - marketscreener.com
Elevance says healthcare demand tracks expectations after UnitedHealth's forecast cut - marketscreener.com
Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlook - Yahoo Finance
Elevance Health beats Q1 expectations, reaffirms 2025 outlook - Investing.com
Elevance reports lower-than-expected medical costs, confirms profit beat - Reuters
Earnings call transcript: Elevance Health Q1 2025 beats EPS forecast - Investing.com
Is Elevance Health (ELV) The Top Falling Stock with Unusual Volume? - MSN
Elevance Health (ELV) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Elevance sees lower-than-expected medical costs in Q1 - Modern Healthcare
Elevance Health, Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:ELV) - Seeking Alpha
Elevance Health Reports Upbeat Q1 Earnings, Reaffirms Full-Year Guidance: But Retail’s Unimpressed By Stocktwits - Investing.com India
Elevance Health Q1 2025 slides: revenue jumps 15%, EPS grows 10% despite cost pressures - Investing.com Australia
Elevance Health (ELV) Surpasses Q1 Revenue Projections with $48. - GuruFocus
0.52%
0.50%
자본화:
|
볼륨(24시간):